ENLIL THERAPEUTICS
ENLIL THERAPEUTICS
Founded:
2017-11-29
Address:
San Francisco, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
LifeShip
Space and Biotech
Founder
More informations about "Enlil Therapeutics"
Enlil Therapeutics - Crunchbase Company Profile & Funding
Organization. Enlil Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Biotech. San Francisco, California, United States; …See details»
Digital Acceleration for MedTech Innovation | Enlil
3 days ago Organization Types. OEM Startups & Enterprise Teams. The Enlil platform is purpose-built to meet the demanding needs of MedTech, Biotech, …See details»
Enlil 2025 Company Profile: Valuation, Funding
Enlil General Information Description. Developer of cloud-based enterprise …See details»
Enlil, Inc. - The Org
Enlil is a portfolio company of Shifamed, a MedTech innovation hub in Silicon Valley with a long history of success in founding cutting-edge medical device companies and bringing …See details»
Three Lakes Consortium for PF (TLC4PF)
Enlil Therapeutics . Three Lakes Foundation has provided funding to support Enlil Therapeutics in its quest to identify compounds that activate telomerase. Read More. B4PF: Understanding …See details»
Enlil Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. Enlil Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by Aberdeen …See details»
EGCG for IPF | Three Lakes Foundation
ORGANIZATION. EGCG was discovered as an antifibrotic in pre-clinical in vivo studies with a mechanism of action blocking collagen accumulation that was …See details»
Enlil - Crunchbase Company Profile & Funding
Enlil seamlessly integrates Requirements Management, QMS, PLM, MES, ERP, and more, creating an end-to-end digital thread that powers innovation and compliance from ideation to …See details»
The PRECISIONS Study | Three Lakes Foundation
ORGANIZATION. Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) is a comprehensive, multicenter, and multi …See details»
Enlil Therapeutics - Crunchbase
Organization. Enlil Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. ...See details»
An Atlas of IPF Lung Cells | Three Lakes Foundation
ORGANIZATION. This research study was designed to identify the cellular changes that occur in the human lung cells as fibrosis develops. Using a single-cell RNA sequencing technique, the …See details»
Enlil Therapeutics - Three Lakes Foundation 2/3
Enlil Therapeutics. ORGANIZATION. Enlil Therapeutics is a start-up company founded to discover cures for telomere-related diseases. Currently, the company is focused on identifying …See details»
The Impact of Antimicrobial Therapy in IPF
ORGANIZATION. Clean-UP IPF was the first pragmatic trial in IPF that studied whether antimicrobial therapy would improve hospitalization or decrease death. Pragmatic trials are …See details»
Enlil Therapeutics, Inc. (Enlil Therapeutics, Inc.) - 药物管线_专利_临 …
May 7, 2025 了解Enlil Therapeutics, Inc. (Enlil Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的。See details»
Enlil Focuses on Accelerating Medical Device Innovation with …
May 12, 2025 Enlil is a specialized solution tailored to meet the product innovation and product development needs of early-stage medical device developers and their ecosystem. Who Enlil …See details»
Enlil Blog
May 15, 2025 In an exclusive conversation with Joe Mullings, Nader Fathi, CEO of Enlil, shares how the company is transforming medical device innovation. In this informative interview, Enlil …See details»
Purpose Built Development Traceability Platform Gains …
Campbell, CA – April 28, 2025 – Enlil, Inc., a Shifamed portfolio company accelerating innovation for regulated products with its comprehensive development traceability platform, today …See details»
Odylia | ReImagining drug development for rare diseases
Odylia Therapeutics is a nonprofit biotech developing therapies for rare diseases that have no available treatment. By integrating scientific knowledge, operational excellence, and …See details»
U.S. FDA Approves EMRELIS™ (telisotuzumab vedotin-tllv) for …
May 14, 2025 "Despite the progress we have seen in the treatment of lung cancer, we need more options for people whose treatments stop working," said Upal Basu Roy, PhD, MPH, …See details»
News Archives | Enlil
Apr 29, 2025 Enlil Blog. Enlil’s Purpose Built Development Traceability Platform Gains Momentum Across the Global MedTech Ecosystem. April 29, 2025 The all-in-one, cloud-native …See details»